Unlock instant, AI-driven research and patent intelligence for your innovation.

Sterilized/permeability-strengthened protein-human acid fibroblast growth factor fusion protein, preparation method and application thereof

A fibroblast and growth factor technology, applied in the field of genetic engineering antibacterial protein preparation, can solve the problems of difficult protease degradation, long half-life, short half-life, etc., and achieve the effects of inhibiting bacterial infection, improving physiological state, and accelerating wound healing

Inactive Publication Date: 2010-09-22
GUANGDONG PHARMA UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] The purpose of the present invention is to provide a bactericidal / permeability enhancing protein-human acidic fibroblast growth factor fusion protein according to the problems of short half-life and easy degradation in existing antibacterial proteins. degraded by protease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sterilized/permeability-strengthened protein-human acid fibroblast growth factor fusion protein, preparation method and application thereof
  • Sterilized/permeability-strengthened protein-human acid fibroblast growth factor fusion protein, preparation method and application thereof
  • Sterilized/permeability-strengthened protein-human acid fibroblast growth factor fusion protein, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] 1. Bactericidal / permeability increasing protein BPI 23 and the cloning of human acidic fibroblast growth factor haFGF

[0040] Complete total RNA was extracted from human peripheral blood leukocytes and fetal brain tissue, reverse-transcribed to synthesize cDNA, and used as BPI 23 and haFGF two gene amplification templates. According to the cDNA sequences of BPI (Genebank accession number: NM_001725) and haFGF (Genebank accession number: S67291) published by Genebank, 4 specific primers P1-P4 were designed using Primer Premier 5.0 and DNA club biological software. The primer sequences are shown in SEQ ID NO : as shown in 2 to 5; using cDNA as template, P1 and P2 as primers to amplify BPI including signal peptide 23 cDNA sequence, the upstream P1 contains the BamH I restriction site, and the downstream P2 contains the Xho I restriction site; P3 and P4 are primers for amplifying the haFGF cDNA sequence, the upstream P3 contains the EcoR I restriction site, and the down...

Embodiment 2

[0051] Example 2 Optimization of Induced Expression Conditions

[0052] According to the above method, inoculate and culture the strain with higher expression level, induce expression in PMSF induction medium with a final concentration of 0.5mM, take samples every 24h from the beginning of induction until the 7th day, and compare the expression at different times by SDS-PAGE amount; then with the best induction time, at different temperatures (24°C, 26°C, 28°C, 30°C), different pH values ​​(4.0, 5.0, 6.0, 7.0), different methanol concentrations (0.5%, 1.0%, 1.5%, 2.0%) to induce expression, and SDS-PAGE to compare the expression levels in various situations to determine the best induction expression conditions.

[0053] The results showed that: 28℃, pH5.0, final concentration of methanol 1.0wt%, final concentration of PMSF 0.5mM, induction 4d were the best expression conditions, and the expression level could reach about 25μg / ml.

Embodiment 3

[0054] Example 3 Expanded expression, purification and concentration of fusion protein

[0055] The optimal expression induction conditions (28°C, pH 5.0, final methanol concentration of 1.0%, PMSF final concentration of 0.5mmol / L, induction expression time of 96h) were used to amplify the expression, and the supernatant was collected and filtered through a 0.22μm microporous filter. After membrane filtration, follow the Bio-Rad protein purification system and HisTrap from Amersham Bioscenes TM Purify according to the HP Kit instructions, elute the target protein with PBS solutions containing different concentrations of imidazole, collect the eluate and SDS-PAGE, dialyze the eluted protein containing the target protein with a dialysis bag with a molecular weight cut-off of 3KD, desalt and freeze-dry Concentrate and store at -70°C for later use.

[0056] SDS-PAGE analysis of the purified eluate collected showed that the eluate of 100mmol / L imidazole contained a large amount o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses sterilized / permeability-strengthened protein-human acid fibroblast growth factor fusion protein, a preparation method and application thereof. According to already disclosed genes of the sterilized / permeability-strengthened protein and gene sequences of the human acid fibroblast growth factor, the sterilized / permeability-strengthened protein-human acid fibroblast growth factor fusion protein in which hydrophobic polypeptide connectors are arranged is obtained by a gene splicing overlap extension method, the sterilized / permeability-strengthened protein-human acid fibroblast growth factor fusion protein is cloned to an expression vector pPICZ alpha A so as to construct an expression vector of the sterilized / permeability-strengthened protein-human acid fibroblast growth factor fusion protein, and the expression vector of the sterilized / permeability-strengthened protein-human acid fibroblast growth factor fusion protein is converted into pichia pastoris X-33 so as to obtain engineering stains which can express the sterilized / permeability-strengthened protein-human acid fibroblast growth factor fusion protein efficiently. The fusion protein can be used for preparing bacteriocides and promoting cell proliferation, and has clinical application value of research on medicaments for curing wound infection or prompting wound healing.

Description

technical field [0001] The invention relates to the field of preparation of genetically engineered antibacterial proteins, in particular to a bactericidal / permeability enhancing protein-human acidic fibroblast growth factor fusion protein and its preparation method and application. Background technique [0002] With the continuous development of modern civilization and high technology, many infectious diseases and malnutrition diseases have been effectively controlled or even basically disappeared, but the trauma has continued unabated. In the world, tens of millions of people are traumatized every year, and more than 2 million people are killed. In my country, millions of people are injured every year, and the number of deaths is at least 200,000. During the wound healing process, the necrotic cells on the damaged wound surface often become the best culture medium for bacteria, which are easy to be infected by bacteria, etc. The endotoxin release and intestinal endotoxin tr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N15/62C12N15/81A61K38/18A61P31/00A61P17/02A61K38/16
Inventor 朱家勇马艳金小宝李小波梅寒芳吴强褚夫江卢雪梅王艳
Owner GUANGDONG PHARMA UNIV